Search reports.
Lymphedema Treatment Market Size, Share & Growth Report 2030
Get free sample report Request for Customiztion Buy Now

Lymphedema Treatment Market Size, Share & Growth Report 2030

Segments - Lymphedema Treatment Market by Types (Secondary Lymphedema and Primary Lymphedema), Treatment Types (Laser Therapy, Physiological Procedures, Drug Therapy, Surgery, Compression Therapy, and Others), Affected Areas (Genitalia, Upper Extremity, and Lower Extremity), Route of administration (Injectable, Oral, and Others), End-users (Specialty Clinics, Ambulatory Surgical Centers, Hospitals, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4391 | 4.4 Rating | 68 Reviews | 190 Pages | Format : PDF Excel PPT

Report Description


The lymphedema treatment market size was valued at USD 840 million in 2021 and is projected to reach USD 1671 million by 2030, expanding at a CAGR of around 9% during the forecast period, 2022 – 2030. The growth of the market is attributed to the rising cases of cancer diseases.

When lymph fluids collect on the fatty tissues beneath the skin, it causes lymphedema. Malfunctioning of lymphatic system also causes lymphedema. It is a condition in which the lower and upper arms swell. Lymphedema is most usually induced by cancer treatment that involves the amputation or destruction of lymph nodes. It is caused by an obstruction in the immune system's lymphatic system. Infections, deformity, chronic pain, and incapacity can all result from a malfunctioning lymphatic system. Lymphoma does not have a cure. Because individuals are dissatisfied or do not get cured with traditional lymphedema treatment, numerous therapies are used instead of standard treatment. They go for an alternate treatment that gives them more influence over medical decisions and is much more suitable with the patient's health-care system.

Lymphedema Treatment Market Summary

Lymphedema can develop as a result of any cancer treatment that interferes with lymph node drainage. It has been known to happen days after breast cancer therapy and up to 30 years later. Therapies, procedures, and lymphovenous transplantation are among the first-line treatments for lymphedema.

The covid-19 pandemic severely affected the lymphedema treatment market. Academic and research institutes, as well as companies in the healthcare industry such as biochemicals, pharmaceuticals, and others, were badly impacted. Patients infected with the coronavirus were being treated in hospitals all around the world. As a result, people with various illnesses were adversely affected. Furthermore, the shutdown impacted the supply chain as well as the market.

  • Rising incidence of breast cancer and lymphedema disorders are projected to drive the market during the forecast period.
  • The adoption of innovative lymphedema treatment products is estimated to fuel the market during the projected period.
  • Government actions and policies to promote lymphedema treatment, as well as private investor funding is expected to have a positive impact on the market growth.
  • Despite technical advances, there is no permanent treatment for lymphedema, which is anticipated to hinder the market growth.
  • High cost associated with the treatment and surgeries is estimated to hamper the market growth.
  • Increased spending on research, development, and healthcare is projected to offer immense opportunities for the market players during the forecast period.

Scope of Lymphedema Treatment Market Report

The report on the global lymphedema treatment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Lymphedema Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2021

Historic Data

2019–2020

Forecast Period

2022 – 2030

Segmentation

Types (Secondary Lymphedema and Primary Lymphedema), Treatment Types (Laser Therapy, Physiological Procedures, Drug Therapy, Surgery, Compression Therapy, and Others), Affected Areas (Genitalia, Upper Extremity, and Lower Extremity), Route of Administration (Injectable, Oral, and Others), End-users (Specialty Clinics, Ambulatory Surgical Centers, Hospitals, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Convatec; AIROS Medical Inc.; Avet Pharmaceuticals; Koya Medical; Huntleigh Healthcare Limited; Cardinal Health; 3M; Juzo; Lohmann & Rausher; Tactile Systems Technology Inc.; Wright Therapy Products; 3A Health Care; Herantis Pharma PLC; SIGVARIS; Bio Compression Systems Inc.; Mego Afek Ltd.; medi GmbH & Co. KG; KOYA MEDICAL; Avet Pharmaceuticals Inc.; and Tactile Medical

Lymphedema Treatment Market Segment Insights

Secondary lymphedema segment held major market share in 2021

Based on types, the market is segregated into secondary lymphedema and primary lymphedema. The secondary lymphedema segment accounted for a major market. Secondary lymphedema develops as a result of cancer treatment that damages the lymphatic system, such as radiation therapy or surgery. Primary lymphedema is caused by the formation of an aberrant lymph cluster. It usually occurs as a result of old age or birth.

Lymphedema Treatment Market Types

Physiological procedures segment is anticipated to expand at a high CAGR during the forecast period

On the basis of treatment types, the market is fragmented into laser therapy, physiological procedures, drug therapy, surgery, compression therapy, and others. The physiological procedures segment is anticipated to expand at a high CAGR during the forecast period owing to the effective therapeutic approaches used on lymphedema patients, such as LVA and VLNT. These two treatments are effective therapy choices for patients with lymphedema.

Lower extremity segment is expected to hold major market share during the forecast period

In terms of affected areas, the market is divided into genitalia, upper extremity, and lower extremity. The lower extremity segment is expected to hold major market share during the forecast period as it is most commonly impacted part. Swelling of the ankles, legs, and feet is common in the lower extremity. One of the more complex disorders is upper extremity disease.

Oral segment dominated the market in 2021

Based on route of administration, the market is segregated into injectable, oral, and others. The oral segment dominated the market in 2021 because it is the most effective route of administration and has a higher level of patient compliance.
 

Lymphedema Treatment Market Route of Administration

The hospitals segment accounted for a major market share in 2021

On the basis of end-users, the market is fragmented into, specialty clinics, ambulatory surgical centers, hospitals, and others. The hospitals segment accounted for a major market share in 2021. Growth of the market is attributed to launch of innovative technologies by the key players for allowing hospitals to make the most of their resources.

Asia Pacific is estimated to register a high CAGR during the forecast period

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is estimated to register a high CAGR during the forecast period owing to rising healthcare expenditure. Due to the country's expanding disposable income, China has dominated the Asia-Pacific market. China has dominated the Asia-Pacific market, due to the country's expanding disposable income.

Lymphedema Treatment Market Regions

Segments

The global lymphedema treatment market has been segmented on the basis of

Types

  • Secondary Lymphedema
  • Primary Lymphedema

Treatment Types

  • Laser Therapy
  • Physiological Procedures
  • Drug Therapy
  • Surgery
  • Compression Therapy
  • Others

Affected Areas

  • Genitalia
  • Upper Extremity
  • Lower Extremity

Route of administration

  • Injectable
  • Oral
  • Others

End-users

  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Hospitals
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Convatec
  • AIROS Medical Inc.
  • Avet Pharmaceuticals
  • Koya Medical
  • Huntleigh Healthcare Limited
  • Cardinal Health
  • 3M
  • Juzo
  • Lohmann & Rausher
  • Tactile Systems Technology Inc.
  • Wright Therapy Products
  • 3A Health Care
  • Herantis Pharma PLC
  • SIGVARIS
  • Bio Compression Systems Inc.
  • Mego Afek Ltd.
  • medi GmbH & Co. KG
  • KOYA MEDICAL
  • Avet Pharmaceuticals Inc.
  • Tactile Medical

Competitive Landscape

Key players competing in the lymphedema treatment market include Convatec; AIROS Medical Inc.; Avet Pharmaceuticals; Koya Medical; Huntleigh Healthcare Limited; Cardinal Health; 3M; Juzo; Lohmann & Rausher; Tactile Systems Technology Inc.; Wright Therapy Products; 3A Health Care; Herantis Pharma PLC; SIGVARIS; Bio Compression Systems Inc.; Mego Afek Ltd.; medi GmbH & Co. KG; KOYA MEDICAL; Avet Pharmaceuticals Inc.; and Tactile Medical. Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market share. For instance,

  • In 2017, Tactile Systems Technology, Inc. introduced Flexitouch, the first pneumatic stimulation device for lymphedema treatment.
  • In September 2020, Paul Hartmann announced a collaboration with Apollo Hospitals Group in West China and India, with an emphasis on wound care clinics and ambulances, as well as medical training.

Lymphedema Treatment Market Key Players

Frequently Asked Questions

Juzo; Lohmann & Rausher; Tactile Systems Technology Inc.; Wright Therapy Products; 3A Health Care are some of the leading players in the lymphedema treatment market.

The lymphedema treatment market size was valued at USD 840 million in 2021.

The lymphedema treatment market is projected to reach USD 1671 million by 2030.

The lymphedema treatment market is projected to expand at a CAGR of around 9% during the forecast period, 2022 – 2030.

The segments provided in the lymphedema treatment market are Types, Treatment Types, Affected Areas, Route of administration, End-users.

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lymphedema Treatment Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Lymphedema Treatment Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Lymphedema Treatment Market - Supply Chain
  4.5. Global Lymphedema Treatment Market Forecast
     4.5.1. Lymphedema Treatment Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Lymphedema Treatment Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Lymphedema Treatment Market Absolute $ Opportunity
5. Global Lymphedema Treatment Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Lymphedema Treatment Market Size and Volume Forecast by Types
     5.3.1. Secondary Lymphedema
     5.3.2. Primary Lymphedema
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Lymphedema Treatment Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Lymphedema Treatment Market Size and Volume Forecast by End Users
     6.3.1. Specialty Clinics
     6.3.2. Ambulatory Surgical Centers
     6.3.3. Hospitals
     6.3.4. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Lymphedema Treatment Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Lymphedema Treatment Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Lymphedema Treatment Demand Share Forecast, 2019-2026
8. North America Lymphedema Treatment Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Lymphedema Treatment Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Lymphedema Treatment Market Size and Volume Forecast by Types
     8.4.1. Secondary Lymphedema
     8.4.2. Primary Lymphedema
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Lymphedema Treatment Market Size and Volume Forecast by End Users
     8.7.1. Specialty Clinics
     8.7.2. Ambulatory Surgical Centers
     8.7.3. Hospitals
     8.7.4. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Lymphedema Treatment Demand Share Forecast, 2019-2026
9. Latin America Lymphedema Treatment Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Lymphedema Treatment Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Lymphedema Treatment Market Size and Volume Forecast by Types
     9.4.1. Secondary Lymphedema
     9.4.2. Primary Lymphedema
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Lymphedema Treatment Market Size and Volume Forecast by End Users
     9.7.1. Specialty Clinics
     9.7.2. Ambulatory Surgical Centers
     9.7.3. Hospitals
     9.7.4. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Lymphedema Treatment Demand Share Forecast, 2019-2026
10. Europe Lymphedema Treatment Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Lymphedema Treatment Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Lymphedema Treatment Market Size and Volume Forecast by Types
     10.4.1. Secondary Lymphedema
     10.4.2. Primary Lymphedema
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Lymphedema Treatment Market Size and Volume Forecast by End Users
     10.7.1. Specialty Clinics
     10.7.2. Ambulatory Surgical Centers
     10.7.3. Hospitals
     10.7.4. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Lymphedema Treatment Demand Share Forecast, 2019-2026
11. Asia Pacific Lymphedema Treatment Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Lymphedema Treatment Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Lymphedema Treatment Market Size and Volume Forecast by Types
     11.4.1. Secondary Lymphedema
     11.4.2. Primary Lymphedema
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Lymphedema Treatment Market Size and Volume Forecast by End Users
     11.7.1. Specialty Clinics
     11.7.2. Ambulatory Surgical Centers
     11.7.3. Hospitals
     11.7.4. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Lymphedema Treatment Demand Share Forecast, 2019-2026
12. Middle East & Africa Lymphedema Treatment Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Lymphedema Treatment Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Lymphedema Treatment Market Size and Volume Forecast by Types
     12.4.1. Secondary Lymphedema
     12.4.2. Primary Lymphedema
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Lymphedema Treatment Market Size and Volume Forecast by End Users
     12.7.1. Specialty Clinics
     12.7.2. Ambulatory Surgical Centers
     12.7.3. Hospitals
     12.7.4. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Lymphedema Treatment Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Lymphedema Treatment Market: Market Share Analysis
  13.2. Lymphedema Treatment Distributors and Customers
  13.3. Lymphedema Treatment Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Convatec
     13.4.2. AIROS Medical Inc.
     13.4.3. Avet Pharmaceuticals
     13.4.4. Koya Medical
     13.4.5. Huntleigh Healthcare Limited
     13.4.6. Cardinal Health
     13.4.7. 3M
     13.4.8. Juzo

Methodology

Our Clients

Honda Motor Co. Ltd.
The John Holland Group
FedEx Logistics
Siemens Healthcare
General Electric
Deloitte
Dassault Aviation
Nestle SA